Brief: Medmix AG Says HY Revenue At CHF 225.4 Million
July 23 (Reuters) - medmix AG MEDX.S: MEDMIX AG: REVENUE AT CHF 225.4M HY MEDMIX AG: REVISED 2025 REVENUE GUIDANCE: DECLINE SIMILAR TO THAT SEEN IN H1 2025 MEDMIX AG - H1 ADJUSTED. EBITDA MARGIN AT 19.9%, +80 BPS YOY MEDMIX AG: CONFIRMED 2025 PROFITABILITY GUIDANCE: ADJUSTED EBITDA MARGIN 18% TO 19% MEDMIX AG: CONFIRMED MID-TERM GUIDANCE: CAGR IN REVENUE OF ABOVE 4%, ADJUSTED. EBITDA MARGIN OF ABOVE 20% Source text: [ID:] Further company coverage: MEDX.S ((Reuters.Briefs@thomsonreuters.com;))